Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2010

Open Access 01-12-2010 | Research

Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe

Authors: Ariane van der Straten, Helen Cheng, Alexandra M Minnis

Published in: Journal of the International AIDS Society | Issue 1/2010

Login to get access

Abstract

Background

We examined the use of male condoms and the diaphragm following completion of a clinical trial of the diaphragm's HIV prevention effectiveness. In the trial, called Methods for Improving Reproductive Health in Africa (MIRA), women were randomized to a diaphragm group (diaphragm, gel and condoms) or a condom-only control group. At trial exit, all women were offered the diaphragm and condoms.

Methods

Our sample consisted of 801 Zimbabwean MIRA participants who completed one post-trial visit (median lapse: nine months; range two to 20 months). We assessed condom, diaphragm and any barrier method use at last sex act at enrolment, final MIRA and post-trial visits. We used multivariable random effects logistic regression to examine changes in method use between these three time points.

Results and discussion

In the condom group, condom use decreased from 86% at the final trial visit to 67% post trial (AOR = 0.20; 95% CI: 0.12 to 0.33). In the diaphragm group, condom use was 61% at the final trial visit, and did not decrease significantly post trial (AOR = 0.77; 95% CI: 0.55 to 1.09), while diaphragm use decreased from 79% to 50% post trial (AOR = 0.18; 95% CI: 0.12 to 0.28). Condom use significantly decreased between the enrolment and post-trial visits in both groups. Use of any barrier method was similar in both groups: it significantly decreased between the final trial and the post-trial visits, but did not change between enrolment and the post-trial visits.

Conclusions

High condom use levels achieved during the trial were not sustained post trial in the condom group. Post-trial diaphragm use remained relatively high in the diaphragm group (given its unknown effectiveness), but was very low in the condom group. Introducing "new" methods for HIV prevention may require time and user skills before they get adopted. Our findings underscore the potential benefit of providing a mix of methods to women as it may encourage more protected acts.
Literature
1.
go back to reference Wong E, Roddy R, Tucker H, Tamoufe U, Ryan K, Ngampoua F: Sex Transm Dis. 2005, 32 (5) : 300–307.CrossRefPubMed Wong E, Roddy R, Tucker H, Tamoufe U, Ryan K, Ngampoua F: Sex Transm Dis. 2005, 32 (5) : 300–307.CrossRefPubMed
2.
go back to reference Ellertson C, Burns M: Re-examining the role of cervical barrier devices. Outlook 2003, 20 (2) : 1–8. Ellertson C, Burns M: Re-examining the role of cervical barrier devices. Outlook 2003, 20 (2) : 1–8.
3.
go back to reference Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J: MIRA Team: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007, 370 (9583) : 251–261.CrossRefPubMed Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Montgomery ET, Fancher H, Cheng H, Rosenblum M, van der Laan M, Jewell N, McIntyre J: MIRA Team: Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial. Lancet 2007, 370 (9583) : 251–261.CrossRefPubMed
4.
go back to reference Ramjee G, van der Straten A, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Cheng H, Montgomery E, Padian N: MIRA team: The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLOS One 2008, 3 (10) : e3488.CrossRefPubMed Ramjee G, van der Straten A, Chipato T, de Bruyn G, Blanchard K, Shiboski S, Cheng H, Montgomery E, Padian N: MIRA team: The diaphragm and lubricant gel for prevention of cervical sexually transmitted infections: results of a randomized controlled trial. PLOS One 2008, 3 (10) : e3488.CrossRefPubMed
5.
go back to reference Sawaya G, Chirenje M, Magure M, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki A, Mutasa R, Chipato T, Smith-McCune K: Effects of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms. Obst Gynecol 2008, 112 (5) : 990–997.CrossRef Sawaya G, Chirenje M, Magure M, Tuveson J, Ma Y, Shiboski S, Da Costa M, Palefsky J, Moscicki A, Mutasa R, Chipato T, Smith-McCune K: Effects of diaphragm and lubricant gel provision on human papillomavirus infection among women provided with condoms. Obst Gynecol 2008, 112 (5) : 990–997.CrossRef
6.
go back to reference van der Straten A, Shiboski S, Montgomery ET, Moore J, De Bruyn G, Ramjee G, Chidanyika A, Kacanek D, Padian N: the MIRA Team: Patterns and predictors of adherence in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr 2009, 50 (4) : 419–426.CrossRefPubMed van der Straten A, Shiboski S, Montgomery ET, Moore J, De Bruyn G, Ramjee G, Chidanyika A, Kacanek D, Padian N: the MIRA Team: Patterns and predictors of adherence in a phase III trial in sub-Saharan Africa: a trajectory analysis. J Acquir Immune Defic Syndr 2009, 50 (4) : 419–426.CrossRefPubMed
7.
go back to reference Minnis AM, Steiner MJ, Gallo MF, Warner L, Hobbs MM, van der Straten A, Chipato T, Macaluso M, Padian NS: Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol 2009, 170 (7) : 918–924.CrossRefPubMed Minnis AM, Steiner MJ, Gallo MF, Warner L, Hobbs MM, van der Straten A, Chipato T, Macaluso M, Padian NS: Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol 2009, 170 (7) : 918–924.CrossRefPubMed
8.
go back to reference Cook LA, Nanda K, Grimes DA: Diaphragm versus diaphragm with spermicides for contraception. Cochrane Database Syst Rev 2003, 1: CD002031.PubMed Cook LA, Nanda K, Grimes DA: Diaphragm versus diaphragm with spermicides for contraception. Cochrane Database Syst Rev 2003, 1: CD002031.PubMed
9.
go back to reference Central Statistical Office (CSO) [Zimbabwe] and Macro International Inc. 2007: Zimbabwe Demographic and Health Survey 2005–06. Calverton, Maryland: CSO and Macro International Inc.; Central Statistical Office (CSO) [Zimbabwe] and Macro International Inc. 2007: Zimbabwe Demographic and Health Survey 2005–06. Calverton, Maryland: CSO and Macro International Inc.;
10.
go back to reference Montgomery ET, Cheng H, van der Straten A, Chidanyika AC, Lince N, Blanchard K, Ramjee G, Nkala B, Padian N: the MIRA Team: Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav 2009, 14 (3) : 629–638.CrossRefPubMed Montgomery ET, Cheng H, van der Straten A, Chidanyika AC, Lince N, Blanchard K, Ramjee G, Nkala B, Padian N: the MIRA Team: Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav 2009, 14 (3) : 629–638.CrossRefPubMed
11.
go back to reference van der Straten A, Kang M, Posner SF, Kamba M, Chipato T, Padian NS: Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis 2005, 32 (1) : 64–71.CrossRefPubMed van der Straten A, Kang M, Posner SF, Kamba M, Chipato T, Padian NS: Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis 2005, 32 (1) : 64–71.CrossRefPubMed
12.
go back to reference Montgomery E, Woodsong C, Musara P, Cheng H, Chipato T, Moench T, Spielberg F, van der Straten A: An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. Journal of the International AIDS Society 2010, 13: 30.CrossRefPubMed Montgomery E, Woodsong C, Musara P, Cheng H, Chipato T, Moench T, Spielberg F, van der Straten A: An acceptability and safety study of the Duet cervical barrier and gel delivery system in Zimbabwe. Journal of the International AIDS Society 2010, 13: 30.CrossRefPubMed
13.
go back to reference Bulut A, Ortayli N, Ringheim K, Cottingham J, Farley TM, Peregoudov A, Joanis C, Palmore S, Brady M, Diaz J, Ojeda G, Ramos R: Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception 2001, 63 (5) : 267–275.CrossRefPubMed Bulut A, Ortayli N, Ringheim K, Cottingham J, Farley TM, Peregoudov A, Joanis C, Palmore S, Brady M, Diaz J, Ojeda G, Ramos R: Assessing the acceptability, service delivery requirements, and use-effectiveness of the diaphragm in Colombia, Philippines, and Turkey. Contraception 2001, 63 (5) : 267–275.CrossRefPubMed
14.
go back to reference Di Giacomo do Lago T, Babose R, Kalckmann S, Villela W, Gohiman S: Acceptability of the diaphragm among low-income women in Sao Paulo, Brazil. Int Fam Plann Perspect 1995, 21: 114–118.CrossRef Di Giacomo do Lago T, Babose R, Kalckmann S, Villela W, Gohiman S: Acceptability of the diaphragm among low-income women in Sao Paulo, Brazil. Int Fam Plann Perspect 1995, 21: 114–118.CrossRef
15.
go back to reference Posner SF, van der Straten A, Kang MS, Padian N, Chipato T: Introducing diaphragms into the mix: what happens to male condom use patterns? AIDS Behav 2006, 9 (4) : 443–449.CrossRef Posner SF, van der Straten A, Kang MS, Padian N, Chipato T: Introducing diaphragms into the mix: what happens to male condom use patterns? AIDS Behav 2006, 9 (4) : 443–449.CrossRef
16.
go back to reference French PP, Latka M, Gollub EL, Rogers C, Hoover DR, Stein ZA: Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis 2003, 30 (5) : 433–439.CrossRefPubMed French PP, Latka M, Gollub EL, Rogers C, Hoover DR, Stein ZA: Use-effectiveness of the female versus male condom in preventing sexually transmitted disease in women. Sex Transm Dis 2003, 30 (5) : 433–439.CrossRefPubMed
17.
go back to reference Gollub EL: Choice is empowering: getting strategic about preventing HIV infection in women. Int Fam Plan Perspect 2006, 32 (4) : 209–212.CrossRefPubMed Gollub EL: Choice is empowering: getting strategic about preventing HIV infection in women. Int Fam Plan Perspect 2006, 32 (4) : 209–212.CrossRefPubMed
18.
go back to reference van der Straten A, Cheng H, Moore J, Kacanek D, Blanchard K, De Bruyn G, Ramjee G, Chipato T, Montgomery ET, Padian N: MIRA Team: The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav 2009, 13 (3) : 564–572.CrossRefPubMed van der Straten A, Cheng H, Moore J, Kacanek D, Blanchard K, De Bruyn G, Ramjee G, Chipato T, Montgomery ET, Padian N: MIRA Team: The use of the diaphragm instead of condoms in a phase III diaphragm trial. AIDS Behav 2009, 13 (3) : 564–572.CrossRefPubMed
19.
go back to reference Kacanek D, Dennis A, Montgomery E, Sahin Hodoglugil N, Morar N, Mtetwa S, Phillip J, Munyoro J, Nkala B, Watadzaushe C, van der Straten A: MIRA Team: Contextual influences on use of the diaphragm and gel without condoms in the methods for improving reproductive health in Africa (MIRA) trial [WEPEO818]. In XVII International AIDS Conference. Mexico City; 2008. Kacanek D, Dennis A, Montgomery E, Sahin Hodoglugil N, Morar N, Mtetwa S, Phillip J, Munyoro J, Nkala B, Watadzaushe C, van der Straten A: MIRA Team: Contextual influences on use of the diaphragm and gel without condoms in the methods for improving reproductive health in Africa (MIRA) trial [WEPEO818]. In XVII International AIDS Conference. Mexico City; 2008.
20.
go back to reference IOM (Institute of Medicine): Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press; 2008. IOM (Institute of Medicine): Methodological Challenges in Biomedical HIV Prevention Trials. Washington, DC: The National Academies Press; 2008.
Metadata
Title
Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe
Authors
Ariane van der Straten
Helen Cheng
Alexandra M Minnis
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2010
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-13-39

Other articles of this Issue 1/2010

Journal of the International AIDS Society 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine